600645.SHG Vcanbio Cell & Gene Engineering Corp Ltd

Healthcare Biotechnology Shanghai Stock Exchange
17.85 CNY
Close of Nov 4, 2026
16.24 32.99
Market cap
CNY 8.35B
P/E
74.4x
P/B
2.11x
ROE
3.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600645.SHG undervalued?

Graham number
Price17.85
Graham value6.77
Premium163.9%

600645.SHG trades 163.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Vcanbio Cell & Gene Engineering Corp Ltd fundamental analysis

No fundamental analysis for Vcanbio Cell & Gene Engineering Corp Ltd yet.

Vcanbio Cell & Gene Engineering Corp Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Vcanbio Cell & Gene Engineering Corp Ltd

Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, engages in the preparation and storage of cell detection tests in the People's Republic of China. It offers cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, immune cells, adipose stem cells and dental stem cells. The company also provides prenatal genetic testing for pregnancy, childr…

Full company profile